Prospective assessment of dosimetric/physiologic- based models for predicting radiation pneumonitis

Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: http://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.

[1]  J. Deasy,et al.  Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. , 2006, International journal of radiation oncology, biology, physics.

[2]  J. Lebesque,et al.  Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival. , 2005, International journal of radiation oncology, biology, physics.

[3]  L. Marks,et al.  Challenges in defining radiation pneumonitis in patients with lung cancer. , 2005, International journal of radiation oncology, biology, physics.

[4]  Joos V Lebesque,et al.  Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[5]  Andrew Jackson,et al.  Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. , 2004, International journal of radiation oncology, biology, physics.

[6]  M. Martel,et al.  Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. , 2004, Lung cancer.

[7]  P. Okunieff,et al.  Radiation and third-generation chemotherapy. , 2004, Hematology/oncology clinics of North America.

[8]  E. Vokes,et al.  Induction chemotherapy and radiotherapy in locally advanced non-small cell lung cancer. , 2004, Hematology/oncology clinics of North America.

[9]  R. Jaszczak,et al.  Predicting RT-induced pulmonary symptoms based on the dose to the superior vs. inferior lung in patients irradiated for lung cancer , 2003 .

[10]  J. Lammers,et al.  Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment. , 2003, Lung cancer.

[11]  R. Clough,et al.  Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer. , 2003, International journal of radiation oncology, biology, physics.

[12]  G. Ceresoli,et al.  Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  G. Starkschall,et al.  Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer. , 2003, International journal of radiation oncology, biology, physics.

[14]  David M. Shade,et al.  Measurement variability in single-breath diffusing capacity of the lung. , 2003, Chest.

[15]  L. Boersma,et al.  Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer. , 2003, International journal of radiation oncology, biology, physics.

[16]  Joos V Lebesque,et al.  Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. , 2003, International journal of radiation oncology, biology, physics.

[17]  L. Boersma,et al.  First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  Lawrence B Marks,et al.  Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. , 2002, International journal of radiation oncology, biology, physics.

[19]  M T Munley,et al.  Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. , 2001, International journal of radiation oncology, biology, physics.

[20]  R. Jaszczak,et al.  Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction? , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  M. O'Doherty,et al.  [(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[22]  R. Jaszczak,et al.  The role of lung perfusion imaging in predicting the direction of radiation‐induced changes in pulmonary function tests , 2000, Cancer.

[23]  L. Boersma,et al.  Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: A follow-up study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  J A Purdy,et al.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.

[25]  L. Boersma,et al.  Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  R K Ten Haken,et al.  Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. , 1998, International journal of radiation oncology, biology, physics.

[27]  M T Munley,et al.  Physical and biological predictors of changes in whole-lung function following thoracic irradiation. , 1997, International journal of radiation oncology, biology, physics.

[28]  M. Kris,et al.  Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  R. Jaszczak,et al.  Quantification of radiation-induced regional lung injury with perfusion imaging. , 1997, International journal of radiation oncology, biology, physics.

[30]  P Schraube,et al.  Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. , 1995, International journal of radiation oncology, biology, physics.

[31]  L B Marks,et al.  The role of three dimensional functional lung imaging in radiation treatment planning: the functional dose-volume histogram. , 1995, International journal of radiation oncology, biology, physics.

[32]  S. McDonald,et al.  Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. , 1995, International journal of radiation oncology, biology, physics.

[33]  L. Boersma,et al.  Dose-effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  N. Choi,et al.  Toxicity of thoracic radiotherapy on pulmonary function in lung cancer. , 1994, Lung cancer.

[35]  R K Ten Haken,et al.  Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. , 1994, International journal of radiation oncology, biology, physics.

[36]  R W de Boer,et al.  A new method to determine dose-effect relations for local lung-function changes using correlated SPECT and CT data. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  T G Turkington,et al.  The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation. , 1993, International journal of radiation oncology, biology, physics.

[38]  J. Lebesque,et al.  The simultaneous boost technique: the concept of relative normalized total dose. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  K. Propert,et al.  A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. , 1990, The New England journal of medicine.

[40]  Thomas J. Gal.  Clinical Respiratory Physiology , 1990 .

[41]  B. Yalcin,et al.  Multidisciplinary management of lung cancer. , 2004, The New England journal of medicine.

[42]  Li Yua.  Three dimensional conformal radiation therapy for non-small cell lung cancer: a phase I/II dose escalation clinical trial , 2003 .

[43]  Masahiro Endo,et al.  Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. , 2003, International journal of radiation oncology, biology, physics.

[44]  R K Ten Haken,et al.  Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  J. Ferlay,et al.  Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .

[46]  T. J. Robnett,et al.  Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. , 2000, International journal of radiation oncology, biology, physics.

[47]  K Hirata,et al.  Risk factors of pneumonitis following chemoradiotherapy for lung cancer. , 1998, European journal of cancer.

[48]  J. Van Dyk,et al.  Radiation-induced lung damage: dose-time-fractionation considerations. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[49]  N. Choi,et al.  Prospective study of pulmonary tolerance to radiotherapy or radiotherapy plus multidrug chemotherapy for loco-regional lung carcinoma. , 1988, Antibiotics and chemotherapy.